We are live on
!
Find out more
GC
Grimes & Company Portfolio holdings
AUM
$4.62B
1-Year Est. Return
29.71%
This Fund
S&P 500
This Quarter
Est. Return
-10.1%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$1.98B
AUM Growth
+$65.7M
(+3.4%)
Cap. Flow
+$343M
Cap. Flow
% of AUM
17.32%
Top 10 Holdings %
Top 10 Hldgs %
50.43%
Holding
310
New
10
Increased
122
Reduced
100
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$316M |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$301M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$23M |
| 4 |
Adobe
ADBE
|
+$13.4M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$11.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$56.5M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$44.1M |
| 3 |
iShares Core S&P Small-Cap ETF
IJR
|
+$43M |
| 4 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$39.4M |
| 5 |
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
|
+$32.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.41% |
| 2 | Healthcare | 8.73% |
| 3 | Financials | 5.55% |
| 4 | Industrials | 4.84% |
| 5 | Communication Services | 3.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Vertex Pharmaceuticals
VRTX
$121B
| – | – |
-911
| Closed | -$238K |
|
302
Warner Bros
WBD
$65.9B
| – | – |
-11,262
| Closed | -$281K |
|
303
State Street Communication Services Select Sector SPDR ETF
XLC
$22.3B
| – | – |
-267,132
| Closed | -$18.4M |
|
304
State Street Industrial Select Sector SPDR ETF
XLI
$32.8B
| – | – |
-246,725
| Closed | -$25.4M |
|
305
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.6B
| – | – |
-3,740
| Closed | -$346K |
|
|
XYZ
306
Block Inc
XYZ
$48.4B
| – | – |
-2,985
| Closed | -$405K |
|
|
CWBR
307
DELISTED
CohBar, Inc. Common Stock
CWBR
| – | – |
-633
| Closed | -$6K |
|
|
AGRX
308
DELISTED
Agile Therapeutics
AGRX
| – | – |
-56
| Closed | -$23K |
|
|
ALBO
309
DELISTED
Albireo Pharma Inc
ALBO
| – | – |
-8,191
| Closed | -$244K |
|
|
ABMD
310
DELISTED
Abiomed Inc
ABMD
| – | – |
-614
| Closed | -$203K |
|
Similar funds
DWM
ANTB
VCM
ACM
AG
SCM
ASC
CWG
Grimes & Company's Q2 2022 Portfolio in Review
As of Q2 2022, Grimes & Company held 310 positions worth $1.98B, up 3.4% from $1.92B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Grimes & Company deployed $343M of net new capital in Q2 2022, opening 10 new positions and adding to 122 existing holdings. Its largest new stake was iShares 0-1 Year Treasury Bond ETF: 2,728,540 shares worth $300M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street Technology Select Sector SPDR ETF, an estimated $56.5M trimmed.
- Grimes & Company's largest Q2 2022 buy was iShares 0-1 Year Treasury Bond ETF: 2,728,540 shares worth $300M.
- Grimes & Company added most to JPMorgan Ultra-Short Income ETF in Q2 2022, an estimated $316M increase.
- Grimes & Company's biggest Q2 2022 reduction was State Street Technology Select Sector SPDR ETF, cutting an estimated $56.5M.
- Grimes & Company fully exited State Street Industrial Select Sector SPDR ETF in Q2 2022, selling an estimated $25.4M.
- Grimes & Company's ten largest holdings make up 50% of its $1.98B portfolio in Q2 2022.
- Grimes & Company opened 10 new positions and closed 37 in Q2 2022.
- Grimes & Company's portfolio value rose 3.4% quarter-over-quarter to $1.98B.
Based on Grimes & Company's 13F filing for Q2 2022, filed 22 Jul 2022.